Evidence map›Paper›PMID 37599958›Full record

ArticleACS omega2023

CO

Tatiana Giannakopoulou, Nadia Todorova, Niki Plakantonaki, Michail Vagenas, Elias Sakellis, Despoina Papargyriou, Marios Katsiotis, Christos Trapalis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tatiana GiannakopoulouInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15341 Agia Paraskevi, Greece.ORCID https://orcid.org/0000-0001-6297-6541
Nadia TodorovaInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15341 Agia Paraskevi, Greece.
Niki PlakantonakiInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15341 Agia Paraskevi, Greece.
Michail VagenasInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15341 Agia Paraskevi, Greece.ORCID https://orcid.org/0000-0002-5510-0004
Elias SakellisInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15341 Agia Paraskevi, Greece.
Despoina PapargyriouGroup Innovation & Technology, TITAN Cement S.A., 11143 Athens, Greece.
Marios KatsiotisGroup Innovation & Technology, TITAN Cement S.A., 11143 Athens, Greece.
Christos TrapalisInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15341 Agia Paraskevi, Greece.
National Centre of Scientific Research "Demokritos" · GRTitan Cement (Greece) · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The conversion of CO

Identifiers

PMID37599958
PMCPMC10433508
OpenAlexW4385411268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.